Kreps Matthew has reported the acquisition of 1,114 shares of common stock in Astrotech Corp, a transaction that underscores the company's strategy to incentivize its leadership. The shares were granted as part of the Astrotech Corporation 2021 Omnibus Equity Incentive Plan, with 100% of the shares vesting immediately on the grant date.
Background
Astrotech Corp, identified by the Central Index Key number 0001001907, operates in the laboratory analytical instruments sector. The company is based in Austin, Texas, and has a fiscal year ending on June 30. Recent filings show that Kreps Matthew is a director at Astrotech Corp, and this acquisition is part of a broader trend in the industry to align executive compensation with company performance.
What the Filing Says
The SEC filing dated October 2, 2026, reveals that Kreps acquired the shares on September 30, 2026. The filing states, "Represents shares of restricted stock granted to the Reporting Person pursuant to the Astrotech Corporation 2021 Omnibus Equity Incentive Plan. 100% of the shares of restricted stock vested immediately on the grant date." This acquisition increases Kreps' total ownership in Astrotech to 3,264 shares.
Impact
This acquisition may influence various stakeholders, including other directors, shareholders, and employees at Astrotech Corp. By granting restricted stock, the company aims to motivate its leadership to drive performance and enhance shareholder value. Such strategies are prevalent in the laboratory analytical instruments sector, where aligning executive interests with those of shareholders is crucial.
What's Next
The filing does not say what happens next.